Examining naltrexone and alcohol effects in a minority population: Results from an initial human laboratory study

American Journal on Addictions

Volumn 20, Issue 4, 2011, Pages 330-336

  Plebani, Jennifer G ^a   Oslin, David W ^a,b   Lynch, Kevin G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; NALTREXONE; PLACEBO;

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG ALCOHOL INTERACTION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SEDATION;

ADULT; AFRICAN AMERICANS; ALCOHOL DRINKING; ALCOHOLISM; BREATH TESTS; DRUG MONITORING; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 79959375894     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00138.x     Document Type: Article

References (32)

1. Pettinati HM, Volpicelli JR, Pierce JD, Jr., et al,. Improving naltrexone response, an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000; 19: 71-83. (Pubitemid 30649833)
2. McCaul ME, Wand GS, Sullivan J, et al,. Beta-naltrexol level predicts alcohol relapse. Alcohol Clin Exp Res. 1997; 21: 32A.
3. Kornet M, Goosen C, van Ree JM,. Opioid modulation of alcohol intake in monkeys by low doses of naltrexone and morphine. Ann N Y Acad Sci. 1991; 469: 471.
4. van Ree JM, Kornet M, Goosen C,. Neuropeptides and alcohol addiction in monkeys. EXS. 1994; 71: 165-174.
5. Ulm RR, Volpicelli JR, Volpicelli LA,. Opiates and alcohol self-administration in animals. J Clin Psyc. 1995; 56: 5-14.
6. Hubbell CL, Czirr SA, Hunter GA, et al,. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 1986; 3: 39-54. (Pubitemid 16143338)
7. Volpicelli JR, Davis MA, Olgin JE,. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci. 1986; 38: 841-847. (Pubitemid 16165575)
8. Froehlich JC, Harts J, Lumeng L, et al,. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav. 1990; 35: 385-390. (Pubitemid 20075583)
9. Swift RM, Whelihan W, Kuznetsov O, et al,. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry. 1994; 151: 1463-1467. (Pubitemid 24301690)
10. O'Malley SS, Jaffe AJ, Chang G, et al,. Naltrexone and coping skills therapy for alcohol dependence, a controlled study. Arch Gen Psychiatry. 1992; 49: 881-887.
11. Ray LA, Oslin DW,. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study. Drug Alcohol Depend 2009; 105: 256-258.
12. King AC, Volpicelli JR, Frazer A, et al,. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology. 1997; 129: 15-22. (Pubitemid 27037445)
13. King A, Schluger J, Gunduz M, et al,. Hypothalamic-pituitary- adrenocorticaI (HPA) axis response and biotransformation of oral naltrexone, preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 1992; 26: 778-788.
14. McCaul ME, Wand GS, Eissenberg T, et al,. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology. 2000; 22: 480-492. (Pubitemid 30145616)
15. McCaul ME, Wand GS, Stauffer R, et al,. Naltrexone dampens ethanol-induced cardiovascular and hypothalamic-pituitary-adrenal axis activation. Neuropsychopharmacology. 2001; 25: 537-547. (Pubitemid 32830958)
16. Volpicelli JR, Watson NT, King AC, et al,. Effect of naltrexone on alcohol "high" in alcoholics. American Journal of Psychiatry. 1995; 152: 613-615.
17. Ray LA, Hutchison KE,. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response, a double-blind placebo-controlled study. Arch Gen Psychiatry. 2007; 64: 1069-1077. (Pubitemid 47360852)
18. Ray LA, Hutchison KE,. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res. 2004; 28: 1789-1795. (Pubitemid 39665194)
19. Pedersen SL, McCarthy DM,. An examination of subjective response to alcohol in African Americans. J Stud Alcohol Drugs. 2009; 70: 288-295.
20. Sheehan DV, Lecrubier Y, Sheehan K, et al,. The Mini-International Neuropsychiatric Interview (M.I.N.I), the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59: 22-33. (Pubitemid 29001829)
21. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9, validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613. (Pubitemid 32823891)
22. Andreasen NC, Rice J, Endicott J, et al,. The family history approach to diagnosis: How useful is it Arch Gen Psychiatry. 1986; 43: 421-429. (Pubitemid 16082745)
23. Sobell LC, Sobell MB,. Timeline follow-back, a technique for assessing self-reported alcohol consumption. In:, Litten R, Allen J, eds. Measuring Alcohol Consumption. Totowa, NJ: Humana Press, Inc.; 1992; 41-65.
24. Roberts JS, Anton RF, Latham PK, et al,. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res. 1999; 23: 1484-1491. (Pubitemid 29468445)
25. Bohn MJ, Barton BA, Barron KE,. Psychometric properties and validity of the obsessive-compulsive drinking scale. Alcohol Clin Exp Res. 1996; 20: 817-823. (Pubitemid 26282313)
26. Kranzler HR, Mulgrew CL, Modesto-Lowe V, et al,. Validity of the Obsessive Compulsive Drinking Scale (OCDS), does craving predict drinking behavior Alcohol Clin Exp Res. 1999; 23: 108-114. (Pubitemid 29068473)
27. Fagerstrom KO, Schneider NG,. Measuring nicotine dependence, a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989; 12: 159-182. (Pubitemid 19191503)
28. Fagerstrom KO,. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978; 3: 235-241.
29. Martin C, Earlywine M, Musty R, et al,. Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res. 1993; 17: 140-146. (Pubitemid 23080981)
30. McNair D, Lorr M, Droppelman L,. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
31. Littell RC, Pendergast J, Natarajan R,. Modeling covariance structure in the analysis of repeated measures data. Stat Med. 2000; 19: 1793-1819. (Pubitemid 30436064)
32. Wang JC, Grucza R, Cruchaga C, et al,. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry. 2009; 14: 501-510.